Number of Chinese outbound investment deals in pharmaceuticals 2016-2019, by type
Investment in the health and pharmaceutical industry slumped in China in 2019 after highly active mergers and acquisitions (M&A) activities in the previous few years. There were 15 outbound investment deals conducted by financial buyers in the pharmaceutical sector from mainland China in 2019, falling from 31 deals in the previous year.